While notable, this is still not enough to move the needle in a meaningful way as far as earnings -- and therefore stock performance -- is concerned.

While we are lowering our [fiscal 2003 earnings estimates] on lower revenue, we continue to believe there are cost savings-driven opportunities beyond the company's $2.5 billion target.

You can always pick up your needle and move to another groove.

I wish I could move that needle further.

I've been pleased with what they've done so far, the group of them. The most notable of them is Carl Bonnell. It's nice to see him back out there and starting to get involved. ... He seems to be moving pretty well.

While our checks suggest that there was a general pickup in hardware business at the end of the March quarter, this was probably not sufficient for IBM to make our original revenue forecasts.